Tag Archives: Yolia Health

angel

Bioscience innovators will pitch at White Hat Investors

Bioindustry Associations from across the Rocky Mountain Southwest Region are coming together to present an opportunity for Angels, Venture Capitalists and Strategic Investors to connect with the biotech and healthcare investment opportunities from across the Rocky Mountain Southwest states at White Hat Investors 2014 in Phoenix, Arizona on September 17 and 18, 2014.

“The West was won by innovators, investors, and prospectors who understood the value of discovery and accepted the challenge of investing in new frontiers,” shared Joan Koerber-Walker, president and CEO of the Arizona Bioindustry Association (AZBio). “Now, industry leaders and accredited investors have the opportunity to meet a new generation of biotech and healthcare pioneers at White Hat 2014, the first annual biotech and healthcare investor conference that showcases the best of the Rocky Mountain Southwest Region.”

White Hat Presenting Companies were selected from the region’s emerging innovation leaders in the fields of Diagnostics, Therapeutics, Medical Devices, and Health IT. Presenting companies are developing lifesaving and life improving innovations that will benefit people today and for generations to come while addressing some of our greatest health challenges including cancer, cardiovascular and pulmonary disease, neurological disorders, infectious disease, and more.

On September 17th, over 400 life science industry leaders will gather to view a company showcase, browse a student discovery zone and listen to presentations from local life science entrepreneurs on the BioAccel Best of the Best Stage from 3:00 p.m. – 6:00 p.m. in the North Ballroom of the Phoenix Convention Center. Free and open to the general public, it presents an opportunity for members of the community to connect with the region’s fastest growing innovation sector. The public pre-event will be followed at 6:00 p.m. by the AZBio Awards gala (registration required) honoring life science pioneer Roy Curtiss, III, PhD; Charles Arntzen, PhD, the Arizona State University Researcher who, with his team, played a key role in the development of ZMAPP, the experimental Ebola drug given to two health workers who were sickened by the deadly virus earlier this year; W.J. “Jim” Lane, Mayor of the City of Scottsdale for his work in developing the Scottsdale Cure Corridor; innovative educator Miles Orchinik, PhD of the School of Life Sciences at Arizona State University; Jack B. Jewett of the Flinn Foundation for leadership of the longest running statewide bioscience development initiative in the United States; emerging technology leaders SenesTech, Pinnacle Transplant Technologies, and Cancer Prevention Pharmaceuticals along with the 2014 Arizona Bioscience Company of the Year, Insys Therapeutics, Inc.

White Hat events continue on September 18th at the Hyatt Regency in downtown Phoenix with presentations by privately-held life science companies presenting to attending representatives of family offices, investment funds, corporate investment/business development professionals for life science oriented firms (strategic investors), granting foundations, venture capital firms, and accredited investors. In addition to great company presentations in the areas of Medical Devices, Diagnostics, Therapeutics and Health IT, White Hat includes THREE general sessions featuring panel discussions on the investment environment from the perspective of Angels, Strategic Investors, and VCs.
Presenting Companies were selected from the Rocky Mountain Southwest’s emerging innovator leaders in the fields of: Diagnostics, Therapeutics, Medical Devices and Health IT and include:

• Aviratek, LLC
• Breezing
• Calimmune, Inc.
• CardioCreate, Inc.
• Convoy Therapeutics
• DiscGenics
• Elutin Vascular Inc.
• EndoShape, Inc
• Fluonic
• Imagenonics LLC
• Iron Horse Diagnostics
• INanoBio
• Kalos Therapeutics
• Kulira Technologies
• Meditope Biosciences, Inc.
• MSDx
• NeuroRecovery Technologies, Inc.
• NuvoMed
• NuvOx Pharma
• Pediatric Bioscience, Inc
• Portable Genomics, Inc.
• MedTalk Companion (Real Phone Corp)
• Recursion Pharmaceuticals
• RiboMed Biotechnologies
• Savoy Pharmaceuticals
• SenesTech
• Skylit Medical
• Sonoran Biosciences
• T-MedRobotics
• Valley Fever Solutions
• ValveXchange
• ViroCyt
• VisionGate
• Yolia Health

medical.research

City of Peoria honors BioAccel

BioAccel has received the City of Peoria’s 2013 Economic Development Award for the development and management of BioInspire, a medical device-focused accelerator program. MaryAnn Guerra, BioAccel’s CEO, and Thomas Rainey, Director of BioInspire, will accept the award on behalf of BioAccel’s staff, Board and advisors at the Peoria Chamber of Commerce’s Annual Awards Celebration, May 22, 2013.

A City of Peoria-funded initiative, BioInspire was launched by BioAccel on September 25, 2012. To date, it has supported the recruitment of six new portfolio companies providing advisory services, funding, individual and common laboratory space and support services at the 6,800-square-foot facility in Peoria. Arizona Medical Systems, Hildeez, Kulira Technologies, Nasseo, Yolia Health and Stimwave Technologies are located at BioInspire.

“The next several years will be exciting as the City continues to execute its Economic Development Implementation Strategy and nurture this public-private partnership to support the region’s bioscience industry,” said Scott Whyte, the City of Peoria’s economic development services director. “As the clients at BioInspire grow and prosper, they will graduate from the resource rich accelerator program into their own commercial space within the City. BioAccel was chosen for this award based on their leadership and execution in assisting us in stimulating the local and regional economy, and planting the seeds for future growth.”

BioInspire’s goal is to create knowledge industry jobs and entrepreneurial wealth by supporting viable new medical device companies.

“Portfolio companies will play a vital role in Peoria’s economic development through their scalable businesses and the products derived from their innovative research. BioAccel provides critical support for that effort by providing proof-of-concept and seed funding, flexible office and lab space, and business and regulator advisory services. This significantly increases their chances of success,” Guerra said.

BioAccel’s interdisciplinary team manages a rigorous client selection process complemented by an expert advisory council that approves final selection of prospective company applications. The Council of Advisors includes senior managers from Medtronic, Covidien, West Valley Bancorp, HLM Partners, the City of Peoria and capital sources among others.

BioAccel was established to stimulate the development of technologies and spin-off companies based on research conducted at other public and private institutions and by local entrepreneurs.

BioAccel is a nonprofit organization dedicated to translating life science discoveries into new business opportunities that drive economic development. Since its founding in 2009, it has invested close to $2.5 million into companies and projects that have secured over $12.6 million in follow on funding thus far. For more information visit www.bioaccel.org.